Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) and Global Industrial (NYSE:GIC – Get Free Report) are both small-cap industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.
Earnings and Valuation
This table compares Capstone Therapeutics and Global Industrial”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Capstone Therapeutics | $48.11 million | 0.04 | -$21.23 million | ($3.35) | -0.03 |
| Global Industrial | $1.38 billion | 1.22 | $72.10 million | $2.24 | 19.65 |
Global Industrial has higher revenue and earnings than Capstone Therapeutics. Capstone Therapeutics is trading at a lower price-to-earnings ratio than Global Industrial, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Capstone Therapeutics has a beta of -1.5, suggesting that its stock price is 250% less volatile than the S&P 500. Comparatively, Global Industrial has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Profitability
This table compares Capstone Therapeutics and Global Industrial’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Capstone Therapeutics | -36.51% | -144.43% | -40.48% |
| Global Industrial | 6.06% | 21.49% | 11.60% |
Insider and Institutional Ownership
2.5% of Capstone Therapeutics shares are held by institutional investors. Comparatively, 31.2% of Global Industrial shares are held by institutional investors. 39.3% of Capstone Therapeutics shares are held by insiders. Comparatively, 64.5% of Global Industrial shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Capstone Therapeutics and Global Industrial, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
| Global Industrial | 0 | 3 | 0 | 0 | 2.00 |
Global Industrial has a consensus target price of $39.00, indicating a potential downside of 11.39%. Given Global Industrial’s stronger consensus rating and higher probable upside, analysts plainly believe Global Industrial is more favorable than Capstone Therapeutics.
Summary
Global Industrial beats Capstone Therapeutics on 12 of the 12 factors compared between the two stocks.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
About Global Industrial
Global Industrial Company operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in North America. It offers storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, foodservice and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials. The company offers industrial and MRO products under the Global, GlobalIndustrial.com, Nexel, Paramount, Interion, and Absocold trademarks. It serves businesses; state, local, and private educational organizations; and government entities through relationship marketers, e-commerce sites, signature campaigns, and catalogs. The company was formerly known as Systemax Inc. Global Industrial Company was founded in 1949 and is headquartered in Port Washington, New York.
Receive News & Ratings for Capstone Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capstone Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
